Insider Trading June 25, 2026 05:06 PM

Core Molding Technologies Director Offloads Shares Amid Leadership Transition

Thomas R. Cellitti's recent divestment coincides with executive changes and mixed Q1 financial results.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
CMT

Thomas R. Cellitti, a director at Core Molding Technologies Inc. (NASDAQ:CMT), executed three separate sales of common stock between June 23 and June 25, 2026. The transactions resulted in a total value of approximately $33,970, with share prices ranging from $24.0 to $24.0662. Following these sales, Cellitti retains a direct holding of 92,393 shares. The insider activity occurs against a backdrop of recent financial reporting and leadership changes within the company.

Core Molding Technologies Director Offloads Shares Amid Leadership Transition
CMT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Thomas R. Cellitti sold 1,413 shares of CMT stock between June 23 and June 25, 2026, for approximately $33,970.
  • Core Molding Technologies reported Q1 2026 earnings of $0.37 per share, beating expectations by 23.33%, but missed revenue targets by 8.69%.
  • President and CEO David L. Duvall is set to step down on June 1, 2026, continuing as a part-time advisor until December 31, 2027.

Thomas R. Cellitti, serving as a director at Core Molding Technologies Inc. (NASDAQ:CMT), has executed a series of divestments involving the company's common stock. Between June 23 and June 25, 2026, Cellitti sold a total of 1,413 shares across three distinct transactions, generating proceeds of approximately $33,970. The shares were disposed of at prices ranging from $24.0 to $24.0662 per share.

The initial transaction occurred on June 23, when Cellitti disposed of 513 shares. This sale was executed through multiple transactions at a weighted average price of $24.0178 per share, with individual prices varying between $24.0 and $24.04. The following day, June 24, Cellitti sold an additional 750 shares at a weighted average price of $24.0662. These specific transactions also involved varying prices, ranging from $24.0 to $24.2. The final transaction took place on June 25, consisting of the sale of 150 shares at a price of $24.0 per share. Following these divestments, Cellitti directly holds 92,393 shares of Core Molding Technologies common stock.

This insider activity unfolds as Core Molding Technologies navigates recent corporate developments. The company recently reported its Q1 2026 earnings, which presented a mixed financial picture. Earnings per share reached $0.37, surpassing the projected $0.30 by 23.33%. However, revenue fell short of expectations, reporting $58.6 million against an anticipated $64.18 million, representing an 8.69% miss. Additionally, Core Molding Technologies announced a planned leadership transition for its President and CEO, David L. Duvall. Duvall is scheduled to step down on June 1, 2026, and will continue serving as a part-time advisor until December 31, 2027. Shareholders recently approved all proposals during the company's annual meeting, with 7,671,210 shares present or represented by proxy.

Market context for CMT shows the stock has delivered strong returns, gaining 42.6% over the past year. According to InvestingPro analysis, the stock currently appears undervalued based on its Fair Value assessment. The company maintains a P/E ratio of 21.33 and has been profitable over the last twelve months. For deeper insights, investors can access CMT's comprehensive Pro Research Report, one of 1,400+ available on InvestingPro, along with additional ProTips for this stock.

In other recent news, Core Molding Technologies reported its Q1 2026 earnings, surpassing expectations with earnings per share of $0.37 compared to the projected $0.30, a 23.33% surprise. However, the company faced a revenue shortfall, reporting $58.6 million against the anticipated $64.18 million, marking an 8.69% miss. Additionally, Core Molding Technologies announced a planned leadership transition for its President and CEO, David L. Duvall, who will step down on June 1, 2026, and continue as a part-time advisor until December 31, 2027. Shareholders recently approved all proposals during the company's annual meeting, with 7,671,210 shares present or represented by proxy. These developments reflect ongoing changes within the company as it navigates its financial and leadership landscape.

Investors monitoring CMT should note the stock's recent performance. As of the latest data, the stock closed at 23.77, reflecting a change of +0.15 (+0.64%). After hours trading saw the stock at 23.77, reflecting a change of -0.17 (-0.71%). The stock's 1D, 1W, 1M, 6M, 1Y, 5Y, and Max performance metrics are available for analysis. Core Molding Technologies is included in AI-picked strategies, and investors can review these strategies for further insight.

For traders analyzing CMT, the conviction gap remains a key consideration. Most traders can read a chart, but the hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. Our chart analysis aims to close this gap. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. This allows investors to know exactly what to do next, every time. Try Chart Analysis for CMT to gain further clarity.

Risks

  • Core Molding Technologies faced a revenue shortfall in Q1 2026, reporting $58.6 million against an anticipated $64.18 million.
  • The company is undergoing a significant leadership transition with the departure of its President and CEO.
  • Investors should monitor the stock's performance closely, as it has gained 42.6% over the past year, potentially indicating volatility.

More from Insider Trading

Avalo Therapeutics CMO Mittie Doyle Executes $26,100 Share Sale Under Pre-Arranged Plan Jun 25, 2026 908 Devices Director Brown Offloads $89,495 in Pre-IPO Equity Jun 25, 2026 908 Devices CEO Kevin Knopp Executes Pre-Arranged Stock Sales Amid Valuation Concerns Jun 25, 2026 Royalty Pharma Executive Sells Shares Under Pre-Arranged Plan Jun 25, 2026 WidePoint COO Todd Dzyak Offloads $240,000 in WYY Shares Amid Strong Stock Performance Jun 25, 2026